Corporate Banner
Satellite Banner
Scientific Community
Join | Sign in

  News Archive

HBV Exposure Matures Infants’ Immune Systems
Saturday, March 28, 2015
Findings presents a paradigm shift in the approach to treatment of patients with chronic hepatitis B.

TxCell to Present at Upcoming US and French Investment Conferences
Saturday, March 28, 2015
Conferences include Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day, New York, March 25 and the Portzamparc PEA-PME Forum, Paris, April 1.

For Most Children with HIV and Low Immune Cell Count, Cells Rebound After Treatment
Saturday, March 28, 2015
NIH-funded study finds T-cell level returns to normal with time.

Takeda Licenses Rights to Use ImmunoGen's ADC Technology
Friday, March 27, 2015
To develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets.

AbbVie and C2N Enter into a Worldwide License Agreement
Friday, March 27, 2015
License agreement to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease.

MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration
Friday, March 27, 2015
MorphoSys regains rights to MOR202 antibody against CD38 and updates its financial guidance for 2015.

Compugen Announces Planned Relocation of Headquarters to Larger Facilities
Wednesday, March 25, 2015
New facilities double available space for corporate offices and research and discovery in Israel.

Celldex Announces Clinical Trial Collaboration with Roche
Friday, March 20, 2015
Collaboration to evaluate the combination of varlilumab and MPDL3280A.

WuXi PharmaTech to Build New Cell Therapy Manufacturing Facility
Friday, March 20, 2015
Facility is designed for CAR T cells and other cancer immunotherapies.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1425

SELECTBIO Market Reports
Go to LabTube
Go to eposters